Ming Hsieh - Nov 1, 2024 Form 4 Insider Report for Fulgent Genetics, Inc. (FLGT)

Role
Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ Paul Kim as Attorney-in-Fact
Stock symbol
FLGT
Transactions as of
Nov 1, 2024
Transactions value $
-$28,893
Form type
4
Date filed
11/5/2024, 04:43 PM
Previous filing
Oct 2, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FLGT Common Stock Tax liability -$28.9K -1.34K -0.19% $21.61 706K Nov 1, 2024 Direct F1
holding FLGT Common Stock 221K Nov 1, 2024 By Trust F2
holding FLGT Common Stock 7.9M Nov 1, 2024 By Trust F3
holding FLGT Common Stock 1K Nov 1, 2024 Uniform Transfer to Minors Account F4
holding FLGT Common Stock 1K Nov 1, 2024 Uniform Transfer to Minors Account F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were withheld by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on August 1, 2022, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on August 3, 2022.
F2 Securities held by the Dynasty Trust. Mr. Hsieh is the grantor of the Dynasty Trust and he and his spouse, Eva Hsieh, and Jian Xie serve on the investment committee of the Dynasty Trust. Mr. Hsieh disclaims any beneficial interest except with respect to any pecuniary interest therein.
F3 Securities held by The Ming Hsieh Trust (the "Hsieh Trust"). Mr. Hsieh is the trustee of the Hsieh Trust and possesses the sole voting and dispositive power with respect to securities held by the Hsieh Trust.
F4 Shares held in a Uniform Transfers to Minor Act account for which Ming Hsieh acts as custodian and possesses the sole voting and dispositive power.